Literature DB >> 781133

Lymphokine-like factors produced by human lymphoid cell lines with B or T cell surface markers.

T Yoshida, T Kuratsuji, A Takada, Y Takada, J Minowada, S Cohen.   

Abstract

In the present series of experiments we examined the ability of eight continuous cell lines derived from human lymphocytes to release lymphokines into their culture media. We have demonstrated that all could produce a macrophage migration inhibitory factor and a neutrophil chemotactic factor. This ability was independent of the B or T cell origin of the cell lines. As a further extension of previous reports, we report that the migration inhibitory effect does not seem to be due to cytotoxic effects as judged by trypan blue exclusion studies, and more important by the demonstration that the inhibition is reversible. The demonstration that neutrophil chemotactic activity is removable by treatment with a previously described and characterized anti-lymphokine antiserum suggests that this factor may be chemically similar to some of the lymphokines (migration inhibitory factor or chemotactic factor for macrophages) produced by antigen-activated guinea pig lymphocyte cultures. The failure to effect similar removal or inactivation of the macrophage migration inhibitory factor may simply reflect greater interspecies heterogeneity in this factor, or more interestingly, that this does not correspond to "classic" MIF. These results extend previous observations by defining further the capacity of lymphoid cell lines in continuous culture to produce mediators and by characterizing their relationship to conventional lymphokines produced by antigen or mitogen-activated lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 781133

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Immunomodulating activity in supernatants from EBV immortalized lymphocytes.

Authors:  B A Blazar; L M Sutton; M Strome
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Lack of correspondence between virus-induced human leukocyte interferon and concanavalin A-induced human migration inhibitory factor (MIF).

Authors:  L H Block; K Cantell; S Bamberger; G Ruhenstroth-Bauer; H Strander
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

Review 3.  The role of cell-mediated immunity in the induction of inflammatory responses. Parke-Davis Award Lecture, 1977.

Authors:  S Cohen
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

4.  Lymphokines: an increasing repertoire.

Authors: 
Journal:  Br Med J       Date:  1978-01-14

5.  Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor.

Authors:  W Y Weiser; P A Temple; J S Witek-Giannotti; H G Remold; S C Clark; J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Effects of soluble mediators generated during growth of the Landschütz ascites carcinoma on the chemotaxis of normal and Corynebacterium parvum-stimulated peritoneal leucocytes.

Authors:  L C McIntosh; A W Thomson
Journal:  Br J Exp Pathol       Date:  1984-08

7.  Lymphoblastoid cell supernatants increase expression of C3b receptors on human polymorphonuclear leucocytes: direct binding studies with 125I-C3b.

Authors:  M Berger; A S Cross
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

8.  The effect of PHA-activated MN-cell supernatants on polymorphonuclear leucocyte function.

Authors:  R Lomnitzer; A Glover; A R Rabson
Journal:  Clin Exp Immunol       Date:  1977-09       Impact factor: 4.330

9.  Characterization of neutrophil and monocyte specific chemotactic factors derived from the cornea in response to hydrogen peroxide injury.

Authors:  S A Elgebaly; N Herkert; J O'Rourke; D L Kreutzer
Journal:  Am J Pathol       Date:  1987-01       Impact factor: 4.307

10.  In vitro synthesis of IgE by human lymphocytes. III. IgE-potentiating activity of culture supernatants from Epstein-Barr virus (EBV) transformed B cells.

Authors:  M Sarfati; E Rector; M Rubio-Trujillo; K Wong; A H Sehon; G Delespesse
Journal:  Immunology       Date:  1984-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.